NCT04630574View on ClinicalTrials.gov

Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions
Huntington Disease
Interventions
OTHER

Speech evaluation with the clinical evaluation of dysarthria

A first speech evaluation with the clinical evaluation of dysarthria during 30 minutes is proposed to exclude very severe dysarthria.

OTHER

complete assessment of the MonPaGe computerized protocol

The application records directly and anonymously stores speech productions made by the patient.

Trial Locations (2)

Unknown

Hôpital Henri-Mondor, Créteil

Centre Hospitalier Universitaire de Bordeaux, Talence

All Listed Sponsors
collaborator

Centre National de la Recherche Scientifique, France

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT04630574 - Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers | Biotech Hunter | Biotech Hunter